Form D · Biotechnology
Inventprise LLC
Redmond, WA · CIK 0001891658
Offering snapshot reported Nov 16, 2021 · SEC filing
- Reported sold
- $3.5M Offering amount: $95M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 1, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2021 | Initial | $3,500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-421257
Source: Form D, filed Nov 16, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pradip Ghate | Executive |
| David Goesling | Executive |
| Subhash Kapre | Director, Executive |
| Yves Leurquin | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
18133 Ne 68 Th St Suite D150
Redmond, WA, 98052
Redmond, WA, 98052